A large, single center investigation of the immunogenetic factors affecting liver transplantation

Transplantation

Volumn 69, Issue 7, 2000, Pages 1491-1498

  Doran, Trevor J ^a,c   Geczy, Andrew F ^a   Painter, Dorothy ^b   McCaughan, Geoffrey ^b   Sheil, A G Ross ^b   Süsal, Caner ^d   Opelz, Gerhard ^d  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c Tissue Typing Laboratory   (Australia)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOGENETICS; IMMUNOGLOBULIN BLOOD LEVEL; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0034655333     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00047     Document Type: Article

References (41)

1. Markus B, Duquesnoy R, Gordon R, et al. Histocompatibility and liver transplant outcome: Does HLA exert a dualistic effect? Transplantation 1988; 46: 372.
2. Donaldson P, Underhill J, Doherty D, et al. Influence of human leucocyte antigen matching on liver allograft survival and rejection: "The dualistic effect." Hepatology 1993; 17: 1008.
3. Nikaein A, Backman L, Jennings L, et al. HLA compatibility and liver transplant outcome: improved patient survival by HLA and crossmatching. Transplantation 1994; 58: 786.
4. Sheil A, Thompson J, McCaughan G, et al. Determinants of successful liver transplantation. Transplant Proc 1990; 22: 2144.
5. Doran T, Derley L, Chapman G, et al. Severity of liver transplantation rejection is associated with recipient HLA type. Transplant Proc 1992; 24: 192.
6. Ratner L, Phelan D, Brunt E, Mohanakumar T, Hanto D. Probable antibody-mediated failure of two sequential ABO-compatible hepatic allografts in a single recipient. Transplantation 1993; 55: 814.
7. Iwatsuki S, Rabin B, Shaw B Jr, Starzl T. Liver transplantation against T cell-positive warm crossmatches. Transplant Proc 1984; 16: 1427.
8. Takaya S, Bronsther O, Iwaki Y, et al. The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992; 53: 400.
9. Doyle H, Marino I, Morelli F, et al. Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 1996; 224: 168.
10. Ogura K, Terasaki P, Koyama H, Chia J, Imagawa D, Busuttil R. High one-month liver graft failure rates in flow cytometry crossmatch-positive recipients. Clin Transplant 1994; 8: 111.
11. Sheil A, McCaughan G, Thompson J, et al. Liver transplantation: An Australian experience. In: Terasaki P, ed. Clinical transplants Los Angeles: UCLA Tissue Typing Laboratory, 1990: 145.
12. Fujita S, Rosen C, Reed A, et al. Significance of preformed anti-donor antibodies in liver transplantation. Transplantation 1997; 63: 84.
13. Talbot D, Bell A, Shenton B, et al. The flow cytometric cross-match in liver transplantation. Transplantation 1995; 59: 737.
14. Karuppan S, Ericzon B, Moller E. Relevance of a positive cross-match on liver transplantation. Transpl Int 1991; 4: 18.
15. Charco R, Vargas V, Balsells J, et al. Influence of anti-HLA antibodies and positive T-lymphocyte crossmatch on survival and graft rejection in human liver transplantation. J Hepatol 1996; 24: 452.
16. Katz S, Kimball P, Ozaki C, et al. Positive pretransplant cross-matches predict early graft loss in liver allograft recipients. Transplantation 1994; 57: 616.
17. Lobo P, Spencer C, Douglas M, Stevenson W, Pruett T. The lack of long-term detrimental effects on liver allografts caused by donor-specific anti-HLA antibodies. Transplantation 1993; 55: 1063.
18. Goggins W, Fisher R, Kimball P, et al. The impact of a positive crossmatch upon outcome after liver transplantation. Transplantation 1996; 62: 1794.
19. Donaldson P, Thomson L, Heads A, et al. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation: an assessment by cytotoxicity and flow cytometry. Transplantation 1995; 60: 1016.
20. Button P, Harmer A, Bayne A, Welsh K. The flow cytometric detection of alloantibodies in screening for renal transplantation. Transpl Int 1995; 8: 360.
21. Neisig A, Melief CJ, Neefjes J. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J Immunol 1998; 160: 171.
22. Chui A, Ling J, McCaughan G, et al. ABO blood group incompatibility in liver transplantation: a single-centre experience. Aust NZJ Surg 1997; 67: 275.
23. Redding R, Veyckemans F, de ville de Goyet J, et al. ABO-incompatible orthotopic liver allografting in urgent indications. Surg Gynecol Obstet 1992; 174: 59.
24. Lo C, Shaked A, Busuttil R. Risk factors for liver transplantation across the ABO barrier. Transplantation 1994; 58: 543.
25. Cicciarelli T, So S, Lim J, Concepcion W, Cox K, Esquivel C. A reassessment of ABO incompatibility in pediatric liver transplants. Transplantation 1995; 60: 757.
26. Sanchez-Urdazpal L, Batts K, Gores G, et al. Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg 1993; 218: 152.
27. Lim E, Terasaki P. High survival rate of kidney transplants in IgA nephropathy patients. In: Terasaki PI ed. Clinical Transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1992; 6:100.
28. Süsal C, Dörr C, Groth J, May G, Opelz G. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival. Transpl Int 1994; 7: S586.
29. 2 activity. Transplantation 1992; 54: 632.
30. Doran T, Süsal C, Opelz G, Geczy A. IgA class antibodies and flow cytometric crossmatching in renal transplantation. Transplantation 1999; 67: 2.
31. Gaudernack G, Leivestad T, Ugelstad J, Thorsby E. Isolation of pure functionally active CDS+ T cells: positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. J Immunol Methods 1986; 90: 179.
32. Mittal K, Mickey M, Singal D, Terasaki P. Serotyping for homotransplantation: refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 1968; 6: 913.
33. Bunce M, O'Neill CM, Barnardo, MC , et al. Phototyping: Comprehensive DNA typing for HLA-A,B,C,DRB1,DRB3,DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355
34. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225.
35. McDonald J, Painter D, Bell R, Gallagher N, Shell A, McCaughan G. Human liver allograft rejection: severity, prognosis, and response to treatment. Transplant Proc 1989; 21: 3792.
36. Süsal C, Wiesel M, Staehler G, Groth J, May G, Opelz G. Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-antiFab autoantibody activity. Transplant Proc 1995; 27: 1072.
37. Matthews D, Farewell V. Using and understanding medical statistics, 2nd Revised Ed. Basel, Switzerland: Karger, 1988.
38. Dawson S III, Imagawa D, Johnson C, et al. UCLA liver transplantation: analysis of immunological factors affecting outcome. Artif Organs 1996; 20: 1063.
39. Wong T, Donaldson P, Devlin J, Williams R. Repeat HLA-B and -DR loci mismatching at second liver transplantation improves patient survival. Transplantation 1996; 61: 440.
40. Francavilla R, Hadzic N, Underbill J, et al. Role of HLA compatibility in pediatric liver transplantation. Transplantation 1998; 66: 53.
41. Opelz G. Newsletter 1:1993 of The Collaborative Transplant Study, Institute for Immunologie, Universitat Heidelberg, Germany. January 20,1993.